April 20, 2022 01:04 PM EDTUpdated April 22, 03:45 PM
Pharma
Law

Supreme Court calls on top gov­ern­ment lawyer to weigh PC­SK9 patent ap­peal

Tyler Patchen

News Reporter

An­oth­er chap­ter in the PC­SK9 bat­tle of Am­gen vs. Sanofi and Re­gen­eron is afoot, with the Supreme Court call­ing on the fed­er­al gov­ern­ment’s top lawyer …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times